Overview

In this video, Dr Prashanth Bagali, Head of Scientific Affairs at MedGenome, explains the causes of hereditary breast cancers, the significance of BRCA gene mutations, and how they can be managed.

Dr Bagali is a leading expert in clinical genomics with over 20 years of experience in precision medicine, medical genetics, and molecular diagnostics. He has contributed extensively to Molecular Tumour Boards across top hospitals in India and abroad, authored 35 peer-reviewed publications, and led over 25 global research projects.

Learn about genetic risk factors, preventive strategies, and the latest advancements in managing hereditary breast cancer. Stay informed and take proactive steps toward your health.

Speakers

Dr Prashanth Bagali

Dr Prashanth Bagali, Head of Scientific Affairs at MedGenome, is a seasoned clinical genomics expert with over two decades of extensive experience in the field of precision medicine, medical genetics, molecular diagnostics, and healthcare innovation. He earned his PhD in Genetics under the prestigious Rockefeller Foundation Fellowship, USA, and pursued post-doctoral research at the National Institutes of Health (NIH), Bethesda, USA. Dr. Bagali is a recognized leader in clinical genomics with deep expertise spanning bioinformatics, medical devices, and translational research. He has significantly contributed to the establishment and functioning of Molecular Tumour Boards across private hospitals and oncology centres of excellence in India and abroad. A recipient of several international research fellowships and awards from the Rockefeller Foundation, Frost & Sullivan, the Federal Government of Malaysia, and private academic institutions, Dr Bagali has authored 35 peer-reviewed publications and successfully led over 25 collaborative research projects globally, reflecting his commitment to advancing healthcare through knowledge sharing and strategic partnerships.